Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2004;103:1118-1120
© 2004 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lacassie, H. J.
Right arrow Articles by López, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lacassie, H. J.
Right arrow Articles by López, H.
Related Collections
Right arrow Critical Care
Right arrow General obstetrics
Right arrow Hypertension and PIH
Right arrow Labor and operative obstetrics
Right arrow Medical complications of pregnancy
Right arrow Prenatal Diagnosis

CASE REPORTS

Management of Eisenmenger Syndrome in Pregnancy With Sildenafil and l-arginine

Héctor J. Lacassie, MD*, Alfredo M. Germain, MD*, Gloria Valdés, MD*, M Soledad Fernández, MD*, Francisco Allamand, MD{dagger} and Héctor López, MD{dagger}

*Pontificia Universidad Católica de Chile, and {dagger}Clínica Santa María, Santiago, Chile

Address reprint requests to: Alfredo M. Germain, MD, Department of Obstetrics and Gynecology, Catholic University School of Medicine, Lira 85-5o Piso, Santiago, Chile; e-mail: agermain{at}med.puc.cl.

BACKGROUND: Eisenmenger syndrome in pregnancy may be a life-threatening disease despite recent additions to the treatment options.

CASE: We present a woman with severe pulmonary hypertension due to Eisenmenger syndrome treated during pregnancy and delivery and postpartum with l-arginine and sildenafil to enhance the nitric oxide pathway. This combination was associated with significant improvement in the mother's clinical and hemodynamic condition and fetal well-being.

CONCLUSION: The concomitant use of sildenafil and l-arginine for the management of pulmonary hypertension in pregnancy, combined with multidisciplinary care, permitted a good outcome for the mother and her infant.




This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
S. Huang and E. R. H. DeSantis
Treatment of pulmonary arterial hypertension in pregnancy
Am. J. Health Syst. Pharm., September 15, 2007; 64(18): 1922 - 1926.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Wareing, J. E. Myers, M. O'Hara, and P. N. Baker
Sildenafil Citrate (Viagra) Enhances Vasodilatation in Fetal Growth Restriction
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2550 - 2555.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Obstetricians and Gynecologists.